reviewEuropean Journal of BiochemistryMar 26, 2003Closed access

Antisense technologies

Freie Universität Berlin

PubMed
Indexed incrossrefpubmed

Abstract

Antisense agents are valuable tools to inhibit the expression of a target gene in a sequence-specific manner, and may be used for functional genomics, target validation and therapeutic purposes. Three types of anti-mRNA strategies can be distinguished. Firstly, the use of single stranded antisense-oligonucleotides; secondly, the triggering of RNA cleavage through catalytically active oligonucleotides referred to as ribozymes; and thirdly, RNA interference induced by small interfering RNA molecules. Despite the seemingly simple idea to reduce translation by oligonucleotides complementary to an mRNA, several problems have to be overcome for successful application. Accessible sites of the target RNA for…

Citation impact

997
total citations
FWCI
28.40
Percentile
100%
References
135
Citations per year

Authors

1

Topics & keywords

Keywords
  • Ribozyme
  • RNA
  • Oligonucleotide
  • Deoxyribozyme
  • Sense (electronics)
  • Small interfering RNA
  • Antisense RNA
  • Computational biology
No related works found for this paper.

Funding